Take Action: Just Say No to Stigmatizing Screening and Unsafe Drugs

Take Action: Just Say No to Stigmatizing Screening and Unsafe Drugs Tue, 26 Oct 2004 FYI /ACTION! AHRP believes that America’s school children should not be screened and labeled without a guarantee of the proven accuracy of the screening tool, and the proven safety and therapeutic value of the treatment…

APA Claims Credit for Censoring News Report about Mental Screening

APA Claims Credit for Censoring News Report about Mental Screening Sun, 16 Oct 2005 The American Psychiatric Association acknowledges its role in suppressing a major news story about the President’s New Freedom Commission Report recommendation. That recommendation is the center of a heated debate among advocates for personal privacy, parental…

Merck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes Drugs

Merck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes Drugs Fri, 10 Jun 2005 A cluster of news reports about three pillars of the pharmaceutical industry– Merck, Eli Lilly, and Johnson & Johnson–leave no doubt that this industry has shown its disregard for the welfare…

Fewer Kids Prescribed Drugs for Depression – WashPost

Fewer Kids Prescribed Drugs for Depression – WashPost Wed, 2 Feb 2005 A report by Medco revealing a decline in SSRI prescriptions for children is giving drug industry stakeholders nightmares about the cash flow. The Washington Post reports "medical groups such as the American Psychiatric Association and the American Academy…

212% Increase in Prescription Drug Abuse by US Teens – Australian critics challenge loose prescribers

212% Increase in Prescription Drug Abuse by US Teens – Australian critics challenge loose prescribers Tue, 27 Sep 2005 Psychiatric prescription drugs have “run amok”: two reports (July, August) by Columbia University’s National Center on Addiction and Substance Abuse, or CASA, confirm an epidemic of prescription drug abuse among teenagers:…

Featured News

AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH re Prozac & Concealed Suicide Attempts Open Letter to Officials at NIMH AHRP Briefing 2/2/04: Scientists present suicide evidence Conflicts of Interest policy – New York Times Phase I Drug Trials Used Foster…

Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo

Reply to the American College of Neuropharmacology’s Report on SSRI and Suicidal Behavior in Children Jonathan Leo, Ph.D. Introduction The American College of Neuropsychopharmacology (ACNP) recently released an Executive Summary from its Task Force on SSRIs and Suicidal Behavior. The task force concluded that "taking Selective Serotonin Reuptake Inhibitors (SSRIs)…

| | |

Screening for Mental Illness: The Merger of Eugenics and the Drug Industry

Ethical Human Psychology and Psychiatry Volume 7, Number 2, Summer 2005 pp. 111-124 Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Vera Hassner Sharav, MLS New York, NY The implementation by the President’s New Freedom Commission (NFC) to screen the entire United States population – children…

Infomail Archive 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

Scientifically unsupportable treatments: Hormone replacement therapy and anti-depression drugs

July 12, 2002 Scientifically unsupportable treatments: Hormone replacement therapy and anti-depression drugs FYI July 11th New York Times Editorial said “The news keeps getting worse about the value of hormone replacement therapies for postmenopausal women,” indicating that “The promotional blitz over the years has made hormone replacement therapy sound like…